For decades, the food industry has marketed low-calorie and artificial sweeteners as "biologically inert" shortcuts—substances that provide the sensory reward...
The global luxury sector, long considered a bastion of resilience against economic volatility, is currently navigating a complex web of...
Popular GLP-1 receptor agonists—most notably Ozempic and Wegovy—have fundamentally reshaped the landscape of metabolic medicine. Initially approved for the management...
The medical community has long operated under a prevailing assumption: as patients shed excess body weight, the physical burden on...
